ADMA Biologics
ADMA
ADMA
19 hedge funds and large institutions have $26M invested in ADMA Biologics in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
22% less capital invested
Capital invested by funds: $33.2M → $26M (-$7.16M)
Holders
19
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.28M | |
| 2 | +$498K | |
| 3 | +$59K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$32.5K |
| 5 |
Renaissance Technologies
New York
|
+$27.9K |
Top Sellers
| 1 | -$2.52M | |
| 2 | -$1.34M | |
| 3 | -$74K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$45.6K |
| 5 |
SIM
Spark Investment Management
New York
|
-$39K |